GSK Stockmann advises Arsipa on acquisition of Munich-based Betriebsmedizin-23 GmbH

European commercial law firm GSK Stockmann provided the Arsipa Group, backed by Warburg Pincus, with comprehensive legal advice on its acquisition of the Munich-based occupational healthcare provider Betriebsmedizin-23 GmbH. This represents a further step in Arsipa’s strategic expansion in the field of occupational medicine and also strengthens its presence in Bavaria.

The acquisition provides a long-term succession solution for the well-established occupational medicine practice Betriebsmedizin-23, ensuring continuity of service for its clients in the greater Munich area. Under the management of Dr Markus Heyenbrock, the practice provides services primarily to small and medium-sized companies in the industrial, service, healthcare and public sectors. Its scope of services includes standard occupational health services, medical check-ups, vaccinations, advice on risk assessments and mental stress, as well as workplace integration management and occupational health and safety training.

Following the acquisition, Betriebsmedizin-23 will benefit from the digital management solutions offered by the Arsipa Group, which will enable it to optimise its administrative processes and ultimately improve medical care. The acquisition takes the Arsipa Group’s network to over 60 locations serving more than 22,000 companies.

A team led by Berlin-based partner Robert Korndörfer advised the Arispa Group on the acquisition.

GSK Stockmann has a proven track record in providing expert advice on transactions in the healthcare sector, having previously advised Arsipa on its acquisition of the occupational healthcare provider Betriebsärzte Allgäu.

Advisers of Arsipa at GSK Stockmann:

Robert Korndörfer (lead, Corporate), Clara López Hernando (Corporate), Stephan Wachsmuth (Tax), Nicole Deparade (Employment Law), Katrin Zukovskaja (Employment Law), Dr Martin Hossenfelder (IP/IT), Dr Maximilian Schnebbe (Data Protection)

GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective.

More about us: www.gsk.de